Survival impact of [225Ac]Ac-DOTATOC alpha-therapy in a preclinical model of pancreatic neuroendocrine tumor liver micrometastases

2024-9-13

Comparison of PSMA immunohistochemistry scoring systems to parametric [18F]PSMA-1007 PET/MRI in primary prostate cancer

2024-9-13

The wings of progress: technological and radiopharmaceutical innovations in nuclear medicine

2024-9-12

The impact of integrating PRIMARY score or SUVmax with MRI-based risk models for the detection of clinically significant prostate cancer

2024-9-12

Long axial field-of-view PET imaging of intraarterial 2-[18F]FDG injection

2024-9-12

Impact of different parametric Patlak imaging approaches and comparison with a 2-tissue compartment pharmacokinetic model with a long axial field-of-view (LAFOV) PET/CT in oncological patients

2024-9-11

Personalised PET imaging in oncology: an umbrella review of meta-analyses to guide the appropriate radiopharmaceutical choice and indication

2024-9-11

EANM position paper on challenges and opportunities of full-ring 360° CZT bone imaging: it’s time to let go of planar whole-body bone imaging

2024-9-11

Discovery of a highly specific radiolabeled antibody targeting B-cell maturation antigen: Applications in PET imaging of multiple myeloma

2024-9-11

ImmunoPET imaging of EpCAM in solid tumours with nanobody tracers: a preclinical study

2024-9-9

Positive amyloid and tau PET in an early-onset Alzheimer’s disease with a rare PSEN1 (Arg278Gly) mutation

2024-9-9

Efficient α and β− radionuclide therapy targeting fibroblast activation protein-α in an aggressive preclinical mouse tumour model

2024-9-6

The LUTADOSE trial: tumour dosimetry after the first administration predicts progression free survival in gastro-entero-pancreatic neuroendocrine tumours (GEP NETs) patients treated with [177Lu]Lu-DOTATATE

2024-9-5

PET/CT with [68Ga]Ga-TEoS-DAZA for localization of a traumatic biliary leak

2024-9-5

Refining salvage radiotherapy strategies for pelvic node recurrence in prostate cancer: insights from salvage lymph node dissection

2024-9-5

Non-invasive diagnosis of liver fibrosis via MRI using targeted gadolinium-based nanoparticles

2024-9-5

Characterization of a gonadal vein Capillary Hemangioma by [68Ga]FAPI-46 and [18 F]FDG PET and immunohistochemistry: a potential pitfall of FAPI PET signal

2024-9-4

Rate of unspecific bone uptake on PSMA PET is determined by the Scaffold – not the Radionuclide. Letter regarding: “The homunculus of unspecific bone uptakes associated with PSMA- targeted tracers: a systematic review-based definition” and “Cutting back on overdiagnosis – Occam’s razor and unspecific bone uptakes in PSMA PET“

2024-9-3

Diagnostic imaging of the diabetic foot

2024-9-3

Efficacy and safety of rechallenge with [177Lu]Lu-PSMA-I&T radioligand therapy in metastatic castration resistant prostate cancer

2024-9-3

Comments on the letter to the editor: “Rate of unspecific bone uptake on PSMA PET is determined by the Scaffold – not the Radionuclide”

2024-9-2

Specific imaging of CD8 + T-Cell dynamics with a nanobody radiotracer against human CD8β

2024-9-2

Degree of amyloid-β burden could be indicative of the primary etiology underlying dementia

2024-8-30

Spatial and temporal tracking of multi-layered cells sheet using reporter gene imaging with human sodium iodide symporter: a preclinical study using a rat model of myocardial infarction

2024-8-29

Correction to: Preclinical SPECT and PET: Joint EANM and ESMI procedure guideline for implementing an efficient quality control programme

2024-8-29

EANM guidelines on the use of [18F]FDG PET/CT in diagnosis, staging, prognostication, therapy assessment, and restaging of plasma cell disorders

2024-8-29

Detection of tumour heterogeneity in patients with advanced, metastatic castration-resistant prostate cancer on [68Ga]Ga-/[18F]F-PSMA-11/-1007, [68Ga]Ga-FAPI-46 and 2-[18F]FDG PET/CT: a pilot study

2024-8-29

Correlation of [68Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients

2024-8-29

False-positive 16α-[18F]Fluoro-17β-Estradiol PET/CT in benign cartilaginous tumor

2024-8-29

PET imaging of synaptic vesicle glycoprotein 2 subtype A for neurological recovery in ischemic stroke

2024-8-28

Preclinical evaluation of the novel [18F]CHDI-650 PET ligand for non-invasive quantification of mutant huntingtin aggregates in Huntington's disease

2024-8-27

[177Lu]Lu DOTATOC PRRT with PARP inhibitors in small cell lung cancer

2024-8-27

Correction to: Targeting of immune checkpoint regulator V-domain Ig suppressor of T-cell activation (VISTA) with 89Zr-labelled CI-8993

2024-8-26

Enhanced detection of damaged myocardium and risk stratification in hypertrophic cardiomyopathy using integrated [68Ga]Ga-FAPI-04 PET/CMR imaging

2024-8-24

Correction to: B-Glycine as a marker for β cell imaging and β cell mass evaluation

2024-8-23

[18F]AlF-CBP imaging of type I collagen for non-invasive monitoring of pulmonary fibrosis in preclinical models

2024-8-22

May the Nuclear Medicine be with you! Neuroendocrine tumours and the return of nuclear medicine

2024-8-19

Spatial-temporal dynamic evolution of lewy body dementia by metabolic PET imaging

2024-8-19

Noninvasive quantification of [18F]SynVesT-1 binding using simplified reference tissue model 2

2024-8-19

Construction and preclinical evaluation of a 124I-labelled bispecific antibody targeting PD-L1 and PD-L2

2024-8-19

Letter to the editor concerning ‘Whole pelvis vs. hemi pelvis elective nodal radiotherapy in patients with PSMA-positive nodal recurrence after radical prostatectomy - a retrospective multi-institutional propensity score analysis.’

2024-8-19

Standardized template for clinical reporting of PSMA PET/CT scans

2024-8-15

Development of [177Lu]Lu-LNC1010 for peptide receptor radionuclide therapy of nasopharyngeal carcinoma

2024-8-15

Identifying the primary tumour in patients with cancer of unknown primary (CUP) using [18F]FDG PET/CT: a systematic review and individual patient data meta-analysis

2024-8-14

Deep learning-aided respiratory motion compensation in PET/CT: addressing motion induced resolution loss, attenuation correction artifacts and PET-CT misalignment

2024-8-13

Outcome prediction based on [18F]FDG PET/CT in patients with pleural mesothelioma treated with ipilimumab and nivolumab +/- UV1 telomerase vaccine

2024-8-12

Exploring the value of FAP-targeted PET/CT in differentiating breast cancer molecular subtypes: a preliminary study

2024-8-12

[99mTc]Tc-hydroxydiphosphonate uptake in soft tissue is associated with amyloid load in subcutaneous abdominal fat tissue and mortality in wild-type transthyretin amyloidosis patients

2024-8-8

Loss of synaptic density in nucleus basalis of meynert indicates distinct neurodegeneration in Alzheimer’s disease: the RJNB-D study

2024-8-8

The impact of PET imaging on triple negative breast cancer: an updated evidence-based perspective

2024-8-7